No mutations of lysophosphatidic acid receptor genes in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats

Journal of Toxicologic Pathology

Volumn 23, Issue 1, 2010, Pages 63-66

  Wakabayashi, Naoko ^a   Tsujino, Megumu ^a   Tajiri, Masaki ^a   Taki, Midori ^a   Koshino, Ayumi ^a   Ikeda, Hiroko ^a   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Lung adenocarcinoma; Lysophosphatidic acid receptor; Mutation; N nitrosobis(2 hydroxypropyl)amine; Rat

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; GENOMIC DNA; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; LYSOPHOSPHATIDIC ACID RECEPTOR 4; LYSOPHOSPHATIDIC ACID RECEPTOR 5; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FROZEN SECTION; GENE MUTATION; HISTOPATHOLOGY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 77953656293     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.23.63     Document Type: Article

References (24)

1. Konishi Y, Denda A, Kondo H, and Takahashi S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. Jpn J Cancer Res. 67: 773-780. 1976.
2. Konishi Y, Kondoh H, Denda A, Takahashi S, and Inui S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. In: Tumors of Early Life in Man and Animals. Perugia Quadrennaial International Conference of Cancer. I Severi (ed.) Division of Cancer Resarch Perugia University, Perugia. 637-649. 1978.
3. Kitada H, Tsutsumi M, Tsujiuchi T, Takahama M, Fukuda T, Narita N, and Konishi Y: Frequent mutations of Ki-ras but no mutations oh Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog. 15: 276-283. 1996.
4. Tsujiuchi T, Sasaki Y, Tsustumi M, and Konishi Y. Mutations, and reduced expression of the transforming growth factor-β receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res. 91: 1090-1095. 2000.
5. Tsujiuchi T, Sasaki Y, Tsustumi M, and Konishi Y. Mutations of the smad2 and smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog. 29: 87-91. 2000.
6. Kato A, Shimizu K, Shimoichi Y, Fujii H, Honoki K, and Tsujiuchi T. Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine. Mol Carcinog. 45: 106-111. 2006.
7. Shimizu K, Itsuzaki Y, Onishi M, Fujii H, Honoki K, and Tsujiuchi T. Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors. Biochem Biophys Res Commun. 347: 358-362. 2006.
8. Ishii I, Fukushima N, Ye X, and Chun J. Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem. 73: 321-354. 2004.
9. Furui T, LaPushin R, Mao M, Khan H, Watt SR, and Watt MAV. Overexpression of Edg-2/vzg-1 Induces apoptosis and anoikis in ovarian cancer cells in a lysophatidic acid-independent manner, Clinical Cancer Res. 5: 4308-4318. 1999.
10. Goetzl EJ, Dolezalova H, Kong Y, Hu YL, Jaffe RB, Kalli KR, and Conover CA. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59: 5370-5375. 1999.
11. Contos JJA, Fukushima N, Weiner JA, Kaushal D, and Chun J. Requirement for the lpA1 lysophosohatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA. 97: 13383-13389. 2000.
12. Contos JJA, Ishii I, Fukushima N, Kingsbury MA, Ye X, Kawamura S, Brown JH, and Chun J. Characterization of 1pa(2) (Edg4) and 1pa(1)/1pa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to 1pa(2). Mol Cell Bio. 22: 6921-6929. 2002.
13. Fang X, Schummer M, Mao M, Yu S, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J, and Mills GB. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta. 1582: 257-264. 2002.
14. Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, and Nakano H. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett. 192: 161-169. 2003.
15. An S, Bleu T, Halmark OG, and Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem. 273: 7906-7910. 1998.
16. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K. Tsujimoto M, and Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem. 274: 27776-27785. 1999.
17. Noguchi K, Ishii S, and Shimizu T. Identification of p2y9/ GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem. 278: 25600-25606. 2003.
18. Lee CW, Rivera R, Gardell S, Dubin AE, and Chun J. GPR92 as a new G12/13 and Gq coupled lysophosphatidic acid receptor that increases cAMP: LPA5. J Biol Chem. 281: 23589-23597. 2006.
19. Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, Kishi Y, Yamaguchi H, Sasaki S, Sako A, Konishi T, Arai H, and Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investigation. 84: 1352-1362. 2004.
20. Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, Honoki K, and Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun. 349: 1151-1155. 2006.
21. Yamada T, Furukawa M, Hotta M, Yamasaki A, Honoki K, Fukushima N, and Tsujiuchi T. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem Biophys Res Commun. 378: 424-427. 2009.
22. Obo Y, Yamada T, Furukawa M, Hotta M, Honoki K, Fukishima N, and Tsujiuchi T. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res. 660: 47-50. 2009.
23. Tsujiuchi T, Shimizu K, Onishi M, Shigemura M, Shano S, Honoki K, and Fukushima N. Aberrant expressions of lysophosphatidic acid receptor genes in lung and liver tumors of rats. J Toxicol Pathol. 19: 137-141. 2006.
24. Tsujiuchi T, Furukawa M, Yamasaki A, Hotta M, Kusunoki C, Suyama N, Mori T, Honoki K, and Fukushima N. Infrequent mutation of lysophosphatidic acid receptor-1 gene in hamster pancreatic duct adenocarcinomas and established cell lines. J Toxicol Pathol. 22: 89-92. 2009.